In recent years, with the continuous development of molecular immunology, immune
checkpoint inhibitors (ICIs) have also been widely used in the treatment of gastric cancer …

Drug resistance, undesirable toxicity and lack of selectivity are the major challenges of
conventional cancer therapies, which cause poor clinical outcomes and high mortality in …

Non-small cell lung cancer (NSCLC) is still challenging for treatment owing to immune
tolerance and evasion. MicroRNA-138 (miR-138) not only acts as a tumor suppressor to …

Resistance to first-line chemotherapy drugs has become an obstacle to improving the
clinical prognosis of patients with small cell lung cancer (SCLC). Exosomal microRNAs have …

Abstract Bacillus Calmette-Guerin (BCG) immunotherapy can prevent recurrence and
progression in selected patients with non-muscle-invasive bladder cancer (NMIBC); …

Pseudomonas aeruginosa is a Gram-negative bacteria and it has been demonstrated that
immunization with the outer membrane proteins of the microbe produces most of the …

Pseudomonas aeruginosa-mannose sensitive hemagglutinin (PA-MSHA) injection serves
as immunological adjuvant in clinical treatment of cancer patients. In present study, we …

Background According to preclinical experiments, Pseudomonas aeruginosa mannose-
sensitive hemagglutinin (PA-MSHA) exerts antiproliferative effects against breast cancer …

Simple Summary Finding the best treatment for cancer remains one of the biggest scientific
challenges in the 21st century. Available cancer treatments have issues like drug resistance …

Objective: This study aims to investigate the therapeutic effects of combining pseudomonas
aeruginosa injection (PAI) with endostar on patients with malignant pleural effusion and …